- Global Pharma News & Resources

Systemic Sclerosis Treatment Market Size to Reach US$ 7.1 Bn by 2032 | CAGR of 5.9%

In 2022, it’s anticipated that the market for systemic sclerosis treatment would be worth US$3.8 billion. According to Future Market Insights (FMI), the market is anticipated to reach a value of US$ 7.1 billion in 2032 and increase at a noteworthy CAGR of 5.9% from 2022 to 2032.

Systemic sclerosis treatment market implies procedures and medicaments for treating systemic connective tissue diseases. In general, systemic sclerosis treatment is carried out treating systemic sclerosis complications such as fibrosis; vasomotor disturbances; subsequent atrophy of the skin; muscles, and internal organs like lung and kidney. Besides systemic sclerosis treatment is also implicated for normalizing immunologic disturbances.

The market of systemic sclerosis treatment is anticipated to witness a healthy growth during the forecast period as systemic sclerosis prevalence is expected to range from 50 to 300 cases per 1 million people in next few years. Amongst these, women are four times more likely to develop the condition than men.

Request Sample Report :

Systemic sclerosis Treatment: Market Dynamics

Systemic sclerosis is a rare disease and its treatment is performed in approximately 67 male patients and 265 female patients per 100,000 people each year globally. Increased investment in research & development for advancements in systemic sclerosis treatment is expected to drive the growth of the market.

Besides, increase in number of government initiatives and programs for disease awareness and treatment is also anticipated to drive the systemic sclerosis treatment market growth. Though systemic sclerosis treatment market is anticipated to see some growth by 2028, still unmet needs need to be addressed. Some major problems such as fail to meet patient needs due to lack of anti-fibrotic drugs and disease-modifying systemic sclerosis therapies; diagnosis delay, and less number of safe and effective systemic sclerosis treatment options. Rheumatologists suggest that one therapy for systemic sclerosis treatment should be made available which can address all disease complications, and could reverse sclerosis.

For this, some pharmaceutical companies have shown renewed interest, and it is anticipated that systemic sclerosis treatment pipeline will see some interesting developments over the forecast period.

Systemic sclerosis Treatment Market: Region-wise Outlook

North America will account for the largest share in global systemic sclerosis treatment market. The European region owing to aggressive healthcare infrastructure will also drive the systemic sclerosis treatment market. Furthermore, the pharmaceutical companies have been showing renewed interests for development of novel drugs for treating systemic sclerosis disease.

Request to View TOC :

For instance, in September, 2016, both USFDA and EMA granted Boehringer Ingelheim International GmbH’s Ofev orphan drug for systemic sclerosis treatment. Due to low disease profile in China, Japan and other Asian countries, East and South Asian countries are expected to be least contributors in the growth of systemic sclerosis treatment market. However, some poor nations especially from MEA region are anticipated to show poor growth in systemic sclerosis treatment market due lack improper healthcare facilities, leading to poor usage of treatment therapeutics

Systemic sclerosis Treatment Market: Key Players

Some of the key players present in global systemic sclerosis treatment market include:

Pfizer, Inc., Cytori Therapeutics, Inc., Acelion Pharmaceuticals, Inc., Bayer AG, Asta Pharma, Boehringer Ingelheim, Eli Lilly, Gilead Sciences, Inc., and Sanofi. In addition, presence of small and local manufacturers across the countries will account for systemic sclerosis treatment market.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Report Ask A Question :

Systemic sclerosis Treatment Market: Segmentation

Segmentation by Therapeutics:

  • Corticosteroids
  • Immunosuppressant
  • Non-steroidal Anti-inflammatory Drugs
  • Blood Pressure medication
  • Light therapy
  • Nitroglycerin Ointment
  • Others

 Segmentation by Disease Type:

  • Limited Cutaneous Systemic Sclerosis
  • Diffuse Cutaneous Systemic Sclerosis

Segmentation by End User:

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

Top Related Reports Healthcare Market Insights

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 15-Nov-2022